ACTIMIS PHARMACEUTICALS

Actimis Pharmaceuticals, Inc., is a start-up biopharmaceutical company focused on the development of small molecule therapeutics for respiratory and inflammatory disorders. Actimis was created as a spin-off from the respiratory diseases therapeutic research portfolio of Bayer Healthcare AG. The spin-off was founded by Dr. Kevin Bacon and has received venture financing from a syndicate lead by Sanderling Ventures of San Mateo, California and Mitsui & Co Venture Partners of New York. Dr. Bacon was most recently Vice President and Global Head of Respiratory diseases research at Bayer Yakuhin Ltd., Japan where the programs were initiated.

#SimilarOrganizations #People #Financial #Website #More

ACTIMIS PHARMACEUTICALS

Industry:

Biotechnology Health Care Medical Pharmaceutical

Founded:

2004-01-01

Address:

San Diego, California, United States

Country:

United States

Website Url:

http://www.actimis.com

Total Employee:

11+

Status:

Active

Contact:

858-458-1890

Total Funding:

15.6 M USD

Technology used in webpage:

SPF Amazon Amazon Frankfurt Region

Similar Organizations

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

Current Employees Featured

not_available_image

Taro Inaba
Taro Inaba Director @ Actimis Pharmaceuticals
Director

not_available_image

Kevin B. Bacon
Kevin B. Bacon Founder, CSO and Head of Research & Development @ Actimis Pharmaceuticals
Founder, CSO and Head of Research & Development

fred-middleton_image

Fred Middleton
Fred Middleton Director @ Actimis Pharmaceuticals
Director

Founder

not_available_image

Kevin B. Bacon

Investors List

sanderling-ventures_image

Official Site Inspections

http://www.actimis.com

Host Informations
Whois Informations

Loading ...